9 Hypertriglyceridaemia, triglyceride-rich lipoproteins and coronary heart disease
Tóm tắt
Từ khóa
Tài liệu tham khảo
Åberg, 1985, Serum triglycerides are a risk factor for myocardial infarction but not for angina pectoris: results from a 10-year follow-up of Uppsala Primary Prevention Study, Atherosclerosis, 54, 89, 10.1016/0021-9150(85)90156-X
Abbott, 1987, Relationships between plasma lipoprotein concentrations and insulin action in an obese hyperinsulinemic population, Diabetes, 36, 897, 10.2337/diabetes.36.8.897
Adams, 1974, The kinetics of plasma free fatty acid and triglyceride transport in patients with idiopathic hypertriglyceridemia and their relation to carbohydrate metabolism, European Journal of Clinical Investigation, 4, 149, 10.1111/j.1365-2362.1974.tb02328.x
Alessi, 1988, Insulin stimulates the synthesis of plasminogen activator inhibitor 1 by the human hepatocellular cell line Hep G2, Thrombosis and Haemostasis, 60, 491, 10.1055/s-0038-1646997
Andersen, 1988, Increased fibrinolytic potential after diet intervention in healthy coronary high-risk individuals, Acta Medica Scandinavica, 223, 499, 10.1111/j.0954-6820.1988.tb17687.x
Andersen, 1990, Effects of gemfibrozil on lipids and haemostasis after myocardial infarction, Thrombosis and Haemostasis, 63, 174, 10.1055/s-0038-1645040
Arbeeny, 1984, The uptake of chylomicron remnants and VLDL remnants by the perfused liver, Journal of Biological Chemistry, 259, 9662, 10.1016/S0021-9258(17)42752-9
Arntzenius, 1985, Diet, lipoproteins, and the progression of coronary atherosclerosis. The Leiden intervention trial, New England Journal of Medicine, 312, 805, 10.1056/NEJM198503283121301
Austin, 1988, Epidemiologic associations between hypertriglyceridemia and coronary heart disease, 14, 143
Austin, 1989, Plasma triglyceride as a risk factor for coronary heart disease: the epidemiologic evidence and beyond, American Journal of Epidemiology, 129, 249, 10.1093/oxfordjournals.aje.a115130
Austin, 1988, Low-density lipoprotein subclass patterns and risk of myocardial infarction, Journal of the American Medical Association, 260, 1917, 10.1001/jama.1988.03410130125037
Aznar, 1988, Plasminogen activator inhibitor activity and other fibrinolytic variables in patients with coronary artery disease, British Heart Journal, 59, 535, 10.1136/hrt.59.5.535
Ballantyne, 1982, High density and low density lipoprotein subfractions in survivors of myocardial infarction and in control subjects, Metabolism, 31, 433, 10.1016/0026-0495(82)90230-X
Barbir, 1988, High prevalence of hypertriglyceridaemia and apolipoprotein abnormalities in coronary artery disease, British Heart Journal, 60, 397, 10.1136/hrt.60.5.397
Barr, 1981, Postprandial exchange of apolipoprotein C-III between plasma lipoproteins, American Journal of Clinical Nutrition, 34, 191, 10.1093/ajcn/34.2.191
Blanche, 1981, Characterization of human high density lipoproteins by gradient gel electrophoresis, Biochimica et Biophysica Acta, 665, 408, 10.1016/0005-2760(81)90253-8
Blankenhorn, 1990, Prediction of angiographic change in native human coronary arteries and aortocoronary bypass grafts: lipid and nonlipid factors, Circulation, 81, 470, 10.1161/01.CIR.81.2.470
Bradley, 1984, Low-density lipoprotein receptor binding determinants switch from apolipoprotein E to apolipoprotein B during conversion of hypertriglyceridemic very-low density lipoprotein to low-density lipoproteins, Journal of Biological Chemistry, 259, 14728, 10.1016/S0021-9258(17)42663-9
Breckenridge, 1982, Lipoprotein abnormalities associated with a familial deficiency of hepatic lipase, Atherosclerosis, 45, 161, 10.1016/0021-9150(82)90136-8
Brenninckmeyer, 1987, Catabolism of chylomicron remnants in normolipidaemic subjects in relation to apoE phenotype, Journal of Lipid Research, 28, 361, 10.1016/S0022-2275(20)38689-2
Brunzell, 1989, Plasma triglyceride levels and coronary disease, New England Journal of Medicine, 320, 1273, 10.1056/NEJM198905113201910
Brunzell, 1976, Myocardial infarction in the familial forms of hypertriglyceridemia, Metabolism, 25, 313, 10.1016/0026-0495(76)90089-5
Cambien, 1986, Is the level of serum triglyceride a significant predictor of coronary death in ‘normocholesterolemic’ subjects? the Paris Prospective Study, American Journal of Epidemiology, 124, 624, 10.1093/oxfordjournals.aje.a114435
Cambien, 1987, Body mass, blood pressure, glucose and lipids. Does plasma insulin explain their relationships?, Arteriosclerosis, 7, 197, 10.1161/01.ATV.7.2.197
Carlson, 1975, Quantitative and qualitative serum lipoprotein analyses. Part 2. Studies in male survivors of myocardial infarction, Atherosclerosis, 21, 435, 10.1016/0021-9150(75)90055-6
Carlson, 1988, Reduction of mortality in the Stockholm Ischaemic Heart Disease Secondary Prevention Study by combined treatment with clofibrate and nicotinic acid, Acta Medica Scandinavica, 223, 405, 10.1111/j.0954-6820.1988.tb15891.x
Carvalho de Sousa, 1989, Coagulation factor VII and plasma triglycerides. Decreased catabolism as a possible mechanism of factor VII hyperactivity, Haemostasis, 19, 125
Castelli, 1986, The triglyceride issue: a view from Framingham, American Heart Journal, 112, 432, 10.1016/0002-8703(86)90296-6
Castro, 1985, Effects of postprandial lipemia on plasma cholesterol metabolism, Journal of Clinical Investigation, 75, 874, 10.1172/JCI111786
Chait, 1984, Low density lipoproteins modified by lipid transfer protein have altered biological activity, Biochimica et Biophysica Acta, 795, 314, 10.1016/0005-2760(84)90081-X
Chang, 1985, Particle size distribution of high density lipoproteins as a function of plasma triglyceride concentration in human subjects, Atherosclerosis, 56, 61, 10.1016/0021-9150(85)90084-X
Chapman, 1988, Further resolution of the low density lipoprotein spectrum in normal human plasma: physicochemical characteristics of discrete subspecies separated by density gradient ultracentrifugation, Journal of Lipid Research, 29, 442, 10.1016/S0022-2275(20)38518-7
Cheung, 1984, Characterization of lipoprotein particles isolated by immunoaffinity chromatography, Journal of Biological Chemistry, 259, 12201, 10.1016/S0021-9258(20)71339-6
Cheung, 1987, Characterization of high density lipoprotein subspecies: structural studies by vertical spin ultracentrifugation and immunoaffinity chromatography, Journal of Lipid Research, 28, 913, 10.1016/S0022-2275(20)38631-4
Cohn, 1988, Postprandial plasma lipoprotein changes in human subjects of different ages, Journal of Lipid Research, 29, 469, 10.1016/S0022-2275(20)38520-5
Cohn, 1988, Plasma apolipoprotein changes in the triglyceride-rich lipoprotein fraction of human subjects fed a fat-rich meal, Journal of Lipid Research, 29, 925, 10.1016/S0022-2275(20)38485-6
Colucci, 1985, Generation in plasma of a fast-acting inhibitor of plasminogen activator in response to endotoxin stimulation, Journal of Clinical Investigation, 75, 818, 10.1172/JCI111777
Conner, 1986, Co-operative studies. Fifteen year mortality in the Coronary Drug Project patients: long-term benefits with niacin, Journal of the American College of Cardiology, 8, 1245, 10.1016/S0735-1097(86)80293-5
Cortner, 1987, Kinetics of chylomicron remnant clearance in normal and hyperlipoproteinemic subjects, Journal of Lipid Research, 28, 195, 10.1016/S0022-2275(20)38721-6
Crouse, 1985, Studies of low density lipoprotein molecular weight in human beings with coronary artery disease, Journal of Lipid Research, 26, 566, 10.1016/S0022-2275(20)34343-1
Daggy, 1986, Enrichment of apolipoprotein B-48 in the low density lipoprotein density class following in vivo inhibition of hepatic lipase, Biochimica et Biophysica Acta, 877, 252, 10.1016/0005-2760(86)90302-4
Dalaker, 1985, A novel form of factor VII in plasma from men at risk for cardiovascular disease, British Journal of Haematology, 61, 315, 10.1111/j.1365-2141.1985.tb02831.x
Dalaker, 1986, A new form of coagulation factor VII in plasma, Scandinavian Journal of Haematology, 36, 430, 10.1111/j.1600-0609.1986.tb02277.x
Dalaker, 1987, Factor VII—phospholipid complex in male survivors of acute myocardial infarction, Acta Medica Scandinavica, 222, 111, 10.1111/j.0954-6820.1987.tb10646.x
Dawson, 1991, Genetic variation at the plasminogen activator inhibitor-1 locus is associated with altered levels of plasma plasminogen activator-1 activity, Arteriosclerosis, 10.1161/01.ATV.11.1.183
Deckelbaum, 1984, Plasma triglyceride determines structure-composition in low and high density lipoproteins, Arteriosclerosis, 4, 225, 10.1161/01.ATV.4.3.225
Deckelbaum, 1988, Conversion of human plasma high density lipoprotein-2 to high density lipoprotein-3. Roles of neutral lipid exchange and triglyceride lipases, Journal of Biological Chemistry, 261, 5201, 10.1016/S0021-9258(19)89234-7
Ducimetiere, 1980, Relationship of plasma insulin levels to the incidence of myocardial infarction and coronary heart disease mortality in middle-aged population, Diabetologia, 19, 205, 10.1007/BF00275270
Eisenberg, 1985, Preferential enrichment of large-sized very low density lipoprotein populations with transferred cholesteryl esters, Journal of Lipid Research, 26, 487, 10.1016/S0022-2275(20)34364-9
Emeis, 1986, Interleukin-1 and lipopolysaccharide induce a fast-acting inhibitor of tissue-type plasminogen activator in vivo and in cultured endothelial cells, Journal of Experimental Medicine, 163, 1260, 10.1084/jem.163.5.1260
Fisher, 1980, The metabolism of apolipoprotein B in subjects with hypertriglyceridemia and polydisperse LDL, Journal of Lipid Research, 21, 760, 10.1016/S0022-2275(20)34803-3
Frick, 1987, Helsinki Heart Study: primary prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease, New England Journal of Medicine, 317, 1237, 10.1056/NEJM198711123172001
Fuller, 1980, Coronary-heart-disease risk and impaired glucose tolerance. The Whitehall Study, Lancet, i, 1373, 10.1016/S0140-6736(80)92651-3
Gianturco, 1990, A cellular basis for the atherogenicity of triglyceride-rich lipoproteins (TGRLP), IS-3
Gianturco, 1983, Apolipoprotein E mediates uptake of Sf 100–400 hypertriglyceridemic very low density lipoproteins by the low density lipoprotein, receptor pathway in normal human fibroblasts, Journal of Biological Chemistry, 258, 4526, 10.1016/S0021-9258(18)32655-3
Gianturco, 1988, Distinct murine macrophage receptor pathway for human triglyceride-rich lipoproteins, Journal of Clinical Investigation, 82, 1633, 10.1172/JCI113775
Ginsberg, 1986, Apolipoprotein B metabolism in subjects with deficiency of apolipoprotein CIII and AI. Evidence that apolipoprotein CIII inhibits catabolism of triglyceride-rich lipoproteins by lipoprotein lipase in vivo, Journal of Clinical Investigation, 78, 1287, 10.1172/JCI112713
Gofman, 1966, Ischemic heart disease, atherosclerosis and longevity, Circulation, 34, 679, 10.1161/01.CIR.34.4.679
Goldberg, 1982, Lipoprotein metabolism during acute inhibition of hepatic triglyceride lipase in the cynomolgus monkey, Journal of Clinical Investigation, 70, 1184, 10.1172/JCI110717
Goldstein, 1980, Cholesteryl ester accumulation in macrophages resulting from receptor-mediated uptake and degradation of hypercholesterolaemic canine beta-very low density lipoproteins, Journal of Biological Chemistry, 255, 1839, 10.1016/S0021-9258(19)85958-6
Groot, 1984, Effects of fat ingestion on high density lipoprotein profiles in human sera, Journal of Lipid Research, 25, 684, 10.1016/S0022-2275(20)37757-9
Groot, 1983, Liver lipase and high-density lipoprotein. Lipoprotein changes after incubation of human serum with rat liver lipase, Biochimica et Biophysica Acta, 751, 393, 10.1016/0005-2760(83)90298-9
Grundy, 1987, 7, 203
Hamsten, 1985, Increased plasma levels of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction, New England Journal of Medicine, 313, 1557, 10.1056/NEJM198512193132501
Hamsten, 1986, Haemostatic function in myocardial infarction, British Heart Journal, 55, 58, 10.1136/hrt.55.1.58
Hamsten, 1986, Serum lipoproteins and apolipoproteins in young male survivors of myocardial infarction, Atherosclerosis, 59, 223, 10.1016/0021-9150(86)90051-1
Hamsten, 1987, Plasminogen activator inhibitor in plasma: risk factor for recurrent myocardial infarction, Lancet, ii, 3, 10.1016/S0140-6736(87)93050-9
Havel, 1984, The formation of LDL: mechanisms and regulation, Journal of Lipid Research, 25, 1570, 10.1016/S0022-2275(20)34434-5
Heiss, 1980, The epidemiology of plasma high-density lipoprotein cholesterol levels: the Lipid Research Clinics Program Prevalence Study, Circulation, 62, 116
Heyden, 1980, Fasting triglycerides as predictors of CHD mortality in Evans County, Georgia, Journal of Chronic Disease, 33, 275, 10.1016/0021-9681(80)90022-3
Hoffman, 1988, Factor VII activity state in coronary artery disease, Journal of Laboratory and Clinical Medicine, 111, 475
Hopkins, 1986, Role of triglyceride-rich lipoproteins and hepatic lipase in determining the particle size and compositions of high density lipoproteins, Journal of Lipid Research, 27, 1265, 10.1016/S0022-2275(20)38740-X
Hopkins, 1985, Role of lipid transfers in the formation of a subpopulation of small high density lipoproteins, Journal of Lipid Research, 26, 218, 10.1016/S0022-2275(20)34392-3
Hulley, 1980, Epidemiology as a guide to clinical decisions. The association between triglyceride and coronary heart disease, New England Journal of Medicine, 302, 1383, 10.1056/NEJM198006193022503
Hunt, 1989, Apolipoprotein, low density lipoprotein subfraction, and insulin associations with familial combined hyperlipidemia. Study of Utah patients with familial dyslipidemic hypertension, Arteriosclerosis, 9, 335, 10.1161/01.ATV.9.3.335
Innerarity, 1978, Enhanced binding by cultured human fibroblasts of apo-E-containing lipoproteins as compared with low density lipoproteins, Biochemistry, 17, 1440, 10.1021/bi00601a013
Jenkins, 1978, Severity of coronary atherosclerosis related to lipoprotein concentration, British Medical Journal, 2, 388, 10.1136/bmj.2.6134.388
Johansson, 1991, High density lipoproteins and coronary atherosclerosis: a strong inverse relation with the largest particles that is confined to normotriglyceridemic patients, Arteriosclerosis, 10.1161/01.ATV.11.1.174
Johnson, 1984, Defective fibrinolysis in survivors of myocardial infarction, International Journal of Cardiology, 6, 380, 10.1016/0167-5273(84)90199-2
Jones, 1951, Lipoproteins in atherosclerosis, American Journal of Medicine, 11, 358, 10.1016/0002-9343(51)90171-4
Juhan-Vague, 1987, Relationships between plasma insulin, triglyceride, body mass index, and plasminogen activator inhibitor 1, Diabetes Metabolism, 13, 331
Juhan-Vague, 1989, Plasma plasminogen activator-inhibitor 1 in angina pectoris. Influence of plasma insulin and acute-phase response, Arteriosclerosis, 9, 362, 10.1161/01.ATV.9.3.362
Kameda, 1984, Increased frequency of lipoprotein disorders similar to type III hyperlipoproteinemia in survivors of myocardial infarction in Japan, Atherosclerosis, 51, 241, 10.1016/0021-9150(84)90171-0
Kane, 1983, Remnants of lipoproteins of intestinal and hepatic origin in familial dysbetalipoproteinemia, Arteriosclerosis, 3, 47, 10.1161/01.ATV.3.1.47
Kesäniemi, 1983, Overproduction of low density lipoproteins associated with coronary heart disease, Arteriosclerosis, 3, 40, 10.1161/01.ATV.3.1.40
Kesäniemi, 1985, Comparisons of metabolism of apolipoprotein B in normal subjects, obese patients, and patients with coronary heart disease, Journal of Clinical Investigation, 76, 586, 10.1172/JCI112010
Kissebah, 1987, Hormones and lipoprotein metabolism, 699
Kleinman, 1985, Defective metabolism of hypertriglyceridemic low density lipoprotein in cultured human skin fibroblasts, Journal of Clinical Investigation, 75, 1796, 10.1172/JCI111892
Kleinman, 1987, Hypolipidemic therapy modulates expression of apolipoprotein B epitopes on low density lipoproteins. Studies in mild to moderate hypertriglyceridemic patients, Journal of Lipid Research, 28, 540, 10.1016/S0022-2275(20)38671-5
Kooistra, 1989, Plasminogen activator inhibitor 1: biosynthesis and mRNA level are increased by insulin in cultured human hepatocytes, Thrombosis and Haemostasis, 62, 723, 10.1055/s-0038-1646891
Krauss, 1987, Intermediate-density lipoproteins and progression of coronary artery disease in hypercholesterolaemic men, Lancet, ii, 62, 10.1016/S0140-6736(87)92734-6
Kukita, 1985, Clinical significance of measurements of serum apolipoprotein A-I, A-II and B in hypertriglyceridemic male patients with and without coronary artery disease, Atherosclerosis, 55, 143, 10.1016/0021-9150(85)90093-0
Landin, 1990, Elevated fibrinogen and plasminogen activator inhibitor (PAI-1) in hypertension are related to metabolic risk factors for cardiovascular disease, Journal of Internal Medicine, 227, 273, 10.1111/j.1365-2796.1990.tb00157.x
Lapidus, 1985, Triglycerides—main lipid risk factor for cardiovascular disease in women?, Acta Medica Scandinavica, 217, 481, 10.1111/j.0954-6820.1985.tb03251.x
Levy, 1984, The influence of changes in lipid values induced by cholestyramine and diet on progression of coronary artery disease: results of the NHBLI type II Coronary Intervention Study, Circulation, 69, 325, 10.1161/01.CIR.69.2.325
Lewis, 1974, Serum lipoprotein abnormalities in patients with ischaemic heart disease: comparisons with a control population, British Medical Journal, 3, 489, 10.1136/bmj.3.5929.489
Lipid Research Clinics Program, 1984, The Lipid Research Clinics Coronary Primary Prevention Trial Results. II. The relationship of reduction of incidence of coronary heart disease to cholesterol lowering, Journal of the American Medical Association, 251, 365, 10.1001/jama.1984.03340270043026
Luc, 1988, Further resolution and comparison of the heterogeneity of plasma low-density lipoproteins in human hyperlipoproteinemias: type III hyperlipoproteinemia, hypertriglyceridemia and familial hypercholesterolemia, Atherosclerosis, 71, 143, 10.1016/0021-9150(88)90138-4
McNamara, 1987, Effect of gender, age, and lipid status on low density lipoprotein subfraction distribution. Results from the Framingham Offspring Study, Arteriosclerosis, 7, 483, 10.1161/01.ATV.7.5.483
Magill, 1982, Relationships between the metabolism of high-density and very low-density lipoproteins in man: studies of apolipoprotein kinetics and adipose tissue lipoprotein lipase activity, European Journal of Clinical Investigation, 12, 113, 10.1111/j.1365-2362.1982.tb00947.x
Mahley, 1980, Cholesteryl ester synthesis in macrophages: stimulation by beta-very low density lipoproteins from cholesterol-fed animals of several species, Journal of Lipid Research, 21, 970, 10.1016/S0022-2275(20)34757-X
Manninen, 1988, Lipid alterations and decline in the incidence of coronary heart disease in the Helsinki Heart Study, Journal of the American Medical Association, 260, 641, 10.1001/jama.1988.03410050061031
Manninen, 1990, The prognostic value of triglycerides in coronary heart disease: experience from the Helsinki Heart study, IS-14
Manolio, 1990, Association of fasting insulin with blood pressure and lipids in young adults. The Cardia study, Arteriosclerosis, 10, 430, 10.1161/01.ATV.10.3.430
Marzetta, 1989, Relationships between LDL density and kinetic heterogeneity in subjects with normolipidemia and familial combined hyperlipidemia using density gradient ultracentrifugation, Journal of Lipid Research, 30, 1307, 10.1016/S0022-2275(20)38258-4
Meade, 1980, Haemostatic function and cardiovascular death: early results of a prospective study, Lancet, i, 1050, 10.1016/S0140-6736(80)91498-1
Meade, 1986, Haemostatic function and cardiovascular death: principal results of the Northwick Park Heart Study, Lancet, ii, 533, 10.1016/S0140-6736(86)90111-X
Mehta, 1987, Plasma tissue plasminogen activator inhibitor levels in coronary artery disease: correlation with age and serum triglyceride concentrations, Journal of the American College of Cardiology, 9, 263, 10.1016/S0735-1097(87)80373-X
Miller, 1986, Association between dietary fat intake and plasma factor VII coagulant activity—a predictor of cardiovascular mortality, Atherosclerosis, 60, 269, 10.1016/0021-9150(86)90174-7
Miller, 1987, Metabolic determinants of plasma high-density lipoprotein concentration in humans, 111
Mitropoulos, 1987, Increased factor VII coagulant activity in the rabbit following diet-induced hypercholesterolaemia. Evidence for increased conversion of VII to VIIa and higher flux within the coagulation pathway, Atherosclerosis, 63, 43, 10.1016/0021-9150(87)90080-3
Mitropoulos, 1989, Factor VII coagulant activity is strongly associated with the plasma concentration of large lipoprotein particles in middle-aged men, Atherosclerosis, 76, 203, 10.1016/0021-9150(89)90104-4
Modan, 1988, Hyperinsulinemia is characterized by jointly disturbed plasma VLDL, LDL, and HDL levels. A population-based study, Arteriosclerosis, 8, 227, 10.1161/01.ATV.8.3.227
Musliner, 1986, Presence of multiple subpopulations of lipoproteins of intermediate size in normal subjects, Arteriosclerosis, 6, 79, 10.1161/01.ATV.6.1.79
Nelson, 1983, Human low density lipoprotein structure: correlations with serum lipoprotein concentrations, Lipids, 18, 553, 10.1007/BF02535396
Nestel, 1983, Slower removal of intestinal apolipoprotein B-48 than of apolipoprotein B-100 in severely hypertriglyceridemic subjects, Biochimica et Biophysica Acta, 751, 422, 10.1016/0005-2760(83)90301-6
Nicoll, 1980, Evaluation of the roles of lipoprotein lipase and hepatic triglyceride lipase in lipoprotein metabolism: in vivo and in vitro studies in man, European Journal of Clinical Investigation, 10, 487, 10.1111/j.1365-2362.1980.tb02090.x
Nikkilä, 1984, Prevention of progression of coronary atherosclerosis by treatment of hyperlipidaemia: a seven year prospective angiographic study, British Medical Journal, 289, 220, 10.1136/bmj.289.6439.220
Nozaki, 1986, The role of hepatic triglyceride lipase in the metabolism of intermediate-density lipoprotein—postheparin lipolytic activities determined by a sensitive, nonradioisotopic method in hyperlipidemic patients and normals, Metabolism, 35, 53, 10.1016/0026-0495(86)90095-8
Olefsky, 1974, Reappraisal of the role of insulin in hypertriglyceridemia, American Journal of Medicine, 57, 551, 10.1016/0002-9343(74)90006-0
Orchard, 1983, Plasma insulin and lipoprotein concentrations: an atherogenic association?, American Journal of Epidemiology, 118, 326, 10.1093/oxfordjournals.aje.a113639
Packard, 1984, Metabolism of apolipoprotein B in large triglyceride-rich very low density lipoproteins of normal and hypertriglyceridemic subjects, Journal of Clinical Investigation, 74, 2178, 10.1172/JCI111644
Paramo, 1985, Plasminogen activator inhibitor in the blood of patients with coronary artery disease, British Medical Journal, 291, 575, 10.1136/bmj.291.6495.573
Patsch, 1983, Inverse relationship between blood levels of high density lipoprotein subfraction 2 and magnitude of postprandial lipemia, 80, 1449
Patsch, 1984, Postprandial lipemia. A key for the conversion of high density lipoprotein2 into high density lipoprotein3 by hepatic lipase, Journal of Clinical Investigation, 74, 2017, 10.1172/JCI111624
Patsch, 1987, High density lipoprotein2. Relationship of the plasma levels of this lipoprotein species to its composition, to the magnitude of postprandial lipemia, and to the activities of lipoprotein lipase and hepatic lipase, Journal of Clinical Investigation, 80, 341, 10.1172/JCI113078
Pyörälä, 1979, Relationship of glucose tolerance and plasma insulin to the incidence of coronary heart disease: results from two population studies in Finland, Diabetes Care, 2, 131, 10.2337/diacare.2.2.131
Pyörälä, 1985, Plasma insulin as coronary heart risk factor: relationship to other risk factors and predictive value during 9½-year follow-up of the Helsinki policeman study population, Acta Medica Scandinavica, 701, 38
Reardon, 1985, Lipoprotein predictors of the severity of coronary artery disease in men and women, Circulation, 71, 881, 10.1161/01.CIR.71.5.881
Reaven, 1988, Banting lecture 1988: role of insulin resistance in human disease, Diabetes, 37, 1595, 10.2337/diabetes.37.12.1595
Shen, 1981, Heterogeneity of serum low density lipoproteins in normal human subjects, Journal of Lipid Research, 22, 236, 10.1016/S0022-2275(20)35367-0
Shepherd, 1987, Metabolic heterogeneity in very low-density lipoproteins, American Heart Journal, 113, 503, 10.1016/0002-8703(87)90621-1
Skartlien, 1989, Effect of alteration in triglyceride levels on favour VII—phospholipid complexes in plasma, Arteriosclerosis, 9, 798, 10.1161/01.ATV.9.6.798
Smith, 1981, Haemostatic factors in human aortic intima, Lancet, i, 1171, 10.1016/S0140-6736(81)92346-1
Smith, 1979, Role of endothelium in sequestration of lipoprotein and fibrinogen in aortic lesions, thrombi and graft pseudointima, Lancet, ii, 812, 10.1016/S0140-6736(79)92173-1
Sniderman, 1980, Association of coronary atherosclerosis with hyperapobetalipoproteinemia (increased protein but normal cholesterol levels in human plasma low density (β) lipoproteins), 77, 604
Sniderman, 1982, Association of hyperapobetalipoproteinemia with endogenous hypertriglyceridemia and atherosclerosis, Annals of Internal Medicine, 97, 833, 10.7326/0003-4819-97-6-833
Stalenhoef, 1984, Metabolism of apo B-48 and B-100 of triglyceride-rich lipoproteins in normal and lipoprotein lipase-deficient humans, 81, 1839
Steiner, 1987, The association of increased levels of intermediate-density lipoproteins with smoking and with coronary artery disease, Circulation, 75, 124, 10.1161/01.CIR.75.1.124
Stiko-Rahm, 1990, Secretion of plasminogen activator inhibitor from cultured human umbilical vein endothelial cells is induced by very low density lipoprotein, Arteriosclerosis, 10.1161/01.ATV.10.6.1067
Swinkels, 1989, The relevance of a protein-enriched low density lipoprotein as a risk for coronary heart disease in relation to other known risk factors, Atherosclerosis, 77, 59, 10.1016/0021-9150(89)90010-5
Swinkels, 1989, Low density lipoprotein subfractions and relationships to other risk factors for coronary artery disease in healthy individuals, Arteriosclerosis, 9, 604, 10.1161/01.ATV.9.5.604
Tall, 1982, Changes in the distribution and composition of plasma high density lipoprotein after ingestion of fat, Journal of Biological Chemistry, 257, 198, 10.1016/S0021-9258(19)68346-8
Tall, 1986, Mechanisms of enhanced cholesteryl ester transfer from high density lipoproteins to apolipoprotein B-containing lipoproteins during alimentary lipemia, Journal of Clinical Investigation, 77, 1163, 10.1172/JCI112417
Taskinen, 1986, High density lipoproteins in postprandial lipemia. Relation to sex and lipoprotein lipase activity, Atherosclerosis, 59, 121, 10.1016/0021-9150(86)90040-7
Tatami, 1981, Intermediate-density lipoprotein and cholesterol-rich very low density lipoprotein in angiographically determined coronary artery disease, Circulation, 64, 1174, 10.1161/01.CIR.64.6.1174
Teng, 1985, Modulation of apolipoprotein B antigenic determinants in human low density lipoprotein subclasses, Journal of Biological Chemistry, 260, 5067, 10.1016/S0021-9258(18)89180-3
Teng, 1986, Metabolic basis of hyperapolipoproteinemia. Turnover of apolipoprotein B in low density lipoprotein and its precursors and subfractions compared with normal and familial hypercholesterolemia, Journal of Clinical Investigation, 77, 663, 10.1172/JCI112360
Thiebaud, 1982, Effect of long chain triglyceride infusion on glucose metabolism in man, Metabolism, 11, 1128, 10.1016/0026-0495(82)90163-9
Tobey, 1981, Relationship between insulin resistance, insulin secretion, very low density lipoprotein kinetics and plasma triglyceride levels in normotriglyceridemic man, Metabolism, 30, 165, 10.1016/0026-0495(81)90167-0
Tremoli, 1990, Hypertriglyceridemia and the fibrinolytic system, IS-24
Vague, 1986, Correlation between blood fibrinolytic activity, plasminogen activator inhibitor level, plasma insulin level and relative body weight in normal and obese subjects, Metabolism, 2, 250, 10.1016/0026-0495(86)90209-X
Vague, 1987, Metformin decreases the high plasminogen activator inhibitor capacity, plasma insulin and triglyceride levels in non-diabetic obese subjects, Thrombosis and Haemostasis, 57, 326, 10.1055/s-0038-1651126
van Lenten, 1985, Receptor-mediated uptake of remnant lipoproteins by cholesterol-laden human monocyte—macrophages, Journal of Biological Chemistry, 260, 8783, 10.1016/S0021-9258(17)39420-6
Vega, 1986, Kinetic heterogeneity of low density lipoproteins in primary hypertriglyceridemia, Journal of Lipid Research, 6, 395
Vega, 1985, Low density lipoprotein metabolism in hypertriglyceridemic and normolipidemic patients with coronary heart disease, Journal of Lipid Research, 26, 115, 10.1016/S0022-2275(20)34410-2
Weintraub, 1987, Different patterns of postprandial lipoprotein metabolism in normal, type IIa, type III, and type IV hyperlipoproteinemic individuals. Effects of treatment with cholestyramine and gemfibrozil, Journal of Clinical Investigation, 79, 1110, 10.1172/JCI112926
Welborn, 1979, Coronary heart disease and cardiovascular mortality in Busselton with reference to glucose and insulin concentrations, Diabetes Care, 2, 154, 10.2337/diacare.2.2.154
Wilson, 1985, Postchallenge plasma lipoprotein retinoids: chylomicron remnants in endogenous hypertriglyceridemia, Metabolism, 34, 551, 10.1016/0026-0495(85)90193-3
Wiman, 1990, The fibrinolytic enzyme system and its role in the etiology of thrombotic disease, 16, 207
Windler, 1985, Inhibitory effects of C apolipoproteins from rats and humans on the uptake of triglyceride-rich lipoproteins and their remnants by the perfused rat liver, Journal of Lipid Research, 26, 556, 10.1016/S0022-2275(20)34342-X